HENDERSON, Nev. (PRWEB) November 30, 2020
Bonimedics (a subsidiary company of StartUpPharma Int. AB) responded to a gap in the availability of quality, medical-grade silicone scar treatment options in the Nordic countries of Sweden, Denmark, Norway, and Finland by partnering with the US-based Biodermis. Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management industry for over 30 years. BoniMedics is introducing Pro-Sil, in 4.25g and 17g sticks, as well as Pro-Sil with SPF-15 in both sizes. Additionally, Epi-Derm silicone sheeting and Epifoam compression foam will be offered.
Pro-Sil is revolutionary in its niche market of convenient, silicone-based scar care options because of its proprietary solid stick formulation. Biodermis recently emerged victorious following a legal challenge against a former Northern European distributor who violated the partnership by attempting to replicate patented silicone technology. In an effort to cut costs, the inferior silicone formula was diluted with excess SPF and other ingredients to a point below that which is proven to be effective with scar treatment. Pro-Sil's patented, high silicone content stick formulation has proven itself in clinical trials as equally effective to gel products like Biodermis' own Epi-Derm silicone sheeting. Pro-Sil is the only patented silicone therapy product available in a solid stick.
“This agreement with BoniMedics will ensure the availability of genuine Biodermis products in Northern Europe. BoniMedics has an outstanding track record in the pharmaceutical & medical device arena, but what’s more, is the foundation of our relationship with them. Biodermis has maintained a successful relationship with Bonimedics founders, Hamid Bakhshi and Sara Nikman, for over a decade. We are confident in their ability to promote our proven line of medical scar care solutions while upholding our high standard of customer service," says Dr. Jeff Schleuning, Ph.D., Managing Partner, Biodermis.
Medical grade silicone effectively provides a fully-encapsulating healing environment for scar tissue and allows the ideal concentration of oxygen and moisture at the scar site. Silicone also provides smooth, even coverage across the scar and surrounding healthy tissue area. These factors help to keep the scar tissue pliable, allowing it to blend more completely with surrounding healthy tissue. The end result is a much-improved scar that has a smoother, flatter appearance, and a more natural skin tone.
With a focus on its ongoing and developing partnership with Biodermis, BoniMedics expects to expand on their scar management offerings and explore new markets under their umbrella organization StartUpPharma Int. AB, throughout 2020 and 2021.
BoniMedics, formed in 2020, is driven by over a decade of extensive experience in the medical device sales and distribution arena in the Nordics and Middle East. They are committed to providing quality and clinically proven products to help in the treatment and management of scars and related dermatology issues. BoniMedics can be reached online at BoniMedics.com or by phone at +46 (8) 604 48 88.